Diamond-Blackfan anemia 13 is a rare inherited condition that usually comes to attention in infancy or early childhood. People living with Diamond-Blackfan anemia 13 often have severe anemia, so they may seem very tired, pale, or feed poorly, and some also have growth differences or birth features that vary from person to person. Not everyone will have the same experience, and the early signs of Diamond-Blackfan anemia 13 can be mild in some children and more serious in others. This condition is usually lifelong, and treatment often includes steroid medicine, blood transfusions, and careful follow-up with a blood specialist, with stem cell transplant used in some cases. The outlook depends on how severe Diamond-Blackfan anemia 13 is and how well treatment works, but serious complications can happen without proper care.
How many people live with Diamond-blackfan anemia 13?
Rare-disease estimates vary by how cases are counted, but Diamond-Blackfan anemia overall is thought to affect about 8,000 to 73,000 people worldwide, based on a prevalence of 1 to 9 per million (Orphanet, 2024); because reports suggest the RPL35A gene-related form makes up about 2% to 4% of cases, Diamond-Blackfan anemia 13 is estimated at roughly 160 to 2,900 people worldwide, although this is an estimate rather than a direct count (GeneReviews, 2020). In the United States, that same overall range works out to about 340 to 3,100 people with Diamond-Blackfan anemia (Orphanet, 2024), so Diamond-Blackfan anemia 13 likely affects about 7 to 120 people, again as an estimate rather than a direct count (GeneReviews, 2020).
Overview
Diamond-blackfan anemia 13Symptoms
Diamond-Blackfan anemia 13 often shows severe anemia in infancy, causing pale skin, poor feeding, tiredness, and fast breathing. Some babies also have slow growth or birth differences such as thumb, heart, or facial features.
Outlook and prognosis
Diamond-Blackfan anemia 13 often lasts long term, but outlook varies with how well anemia responds to treatment and whether birth differences or growth problems are present. Many living with Diamond-Blackfan anemia 13 can do well with ongoing specialist care and regular monitoring.
Causes and risk factors
Diamond-Blackfan anemia 13 is usually caused by a change in the RPS19 gene, often new but sometimes inherited. Family history raises risk, while nutrition, infections, and other exposures do not cause it, though they can affect symptoms or complications.
Genetic influences
Genetics are central to Diamond-Blackfan anemia 13, which is usually caused by a harmful change in a single gene. These genetic variations often explain why it runs in families, though severity can vary even among relatives.
Diagnosis
Diamond-Blackfan anemia 13 is usually suspected from clinical features and blood tests showing low red blood cell production. The genetic diagnosis of Diamond-Blackfan anemia 13 is confirmed with genetic testing, and some people also need bone marrow testing.
Treatment and drugs
Diamond-Blackfan anemia 13 is usually treated with steroid medicine to help the bone marrow make more red blood cells. Some people need regular blood transfusions. If iron builds up, chelation may help, and some may need a stem cell transplant.
Symptoms
Many families first notice that a baby or child looks unusually pale, tires easily, or has trouble feeding and growing as expected. In medical terms, this is anemia; in everyday life, it shows up as low energy and less stamina because the body is not getting enough oxygen. Diamond-Blackfan anemia 13 can also come with differences present from birth, such as changes in the thumbs, face, heart, or kidneys, although not everyone has these. The mix of features can vary a lot from one child to another.
One of the early features of Diamond-Blackfan anemia 13 is skin that looks unusually pale, especially in the lips, gums, or nail beds. This happens because there are too few red blood cells to carry oxygen well.
Babies and children may seem unusually tired, sleepy, fussy, or less interested in feeding and play. Everyday activity can take more effort than expected for age.
Some children breathe faster than usual, seem short of breath, or have a racing heartbeat when feeding, crying, or being active. These are common signs that the body is trying to make up for low oxygen delivery.
Poor feeding in infancy and slow weight gain can happen when anemia is significant. Some children with Diamond-Blackfan anemia 13 are also shorter than expected as they grow.
How people usually first notice Diamond-blackfan anemia 13?
How Diamond-Blackfan anemia 13 is first noticed often begins in the first year of life, when a baby looks unusually pale, tires easily, feeds poorly, or breathes faster than expected because the body is not making enough red blood cells. In many living with this condition, doctors first pick it up after blood tests for anemia, while some families also notice early physical features such as slower growth or differences in the thumbs, face, or palate that can occur in some children but not all. Because the pattern can vary, the first signs of Diamond-Blackfan anemia 13 may be subtle at first, but early medical evaluation can help explain what is happening and guide treatment.
Types of Diamond-blackfan anemia 13
No distinct types of Diamond-Blackfan anemia 13 are widely recognized.
Can I slow down the onset of symptoms?
Probably not: there is no good evidence that lifestyle changes or routine medical steps can meaningfully delay the start of symptoms in Diamond-Blackfan anemia 13, an inherited condition in which the body has trouble making enough red blood cells. Because it is mainly caused by a gene change present from birth, things like diet, exercise, sleep, or vitamins have not been shown to postpone when anemia begins, although research is ongoing to find better treatments. What can help is early medical follow-up, especially if this condition runs in the family, so blood tests and care can catch problems early and treat them promptly, even though this does not prevent the condition.
What genetics can tell you about symptoms
Genetics can give some clues, but not a complete forecast, for people with Diamond-Blackfan anemia 13. Changes in the gene linked to this form can affect how the body makes red blood cells and may also be tied to birth differences or growth problems in some people, but symptoms can vary a lot even within the same family. In general, genetic results may help explain why anemia starts early in life and why some have more severe or broader symptoms than others, yet they usually cannot predict exactly which symptoms will happen or how serious they will be.
Causes and risk factors
The main genetic cause of Diamond-Blackfan anemia 13 is a change in the RPS29 gene. This change may be inherited from a parent or happen for the first time in a child. Family history can raise the chance, but risk can vary widely from person to person. Other genes, overall health, and early development may affect how severe Diamond-Blackfan anemia 13 is. Routine diet, exercise, and common environmental exposures are not known to be the main cause, but general health can still affect day-to-day symptoms of anemia.
What are the most common causes or risk factors?
Diamond-Blackfan anemia 13 is mainly caused by a change in a gene that affects how the bone marrow makes red blood cells, and this change may be passed down from a parent or happen for the first time in a child. The main known risk factor is a family history of Diamond-Blackfan anemia, although many people with this condition are the first in their family to have it. Unlike many common health problems, there are no well-proven lifestyle, diet, or environmental risk factors.
Environmental and biological risk factors
When people look for risk factors for Diamond-Blackfan anemia 13, the answer is narrower than it is for many common conditions. Awareness of both biological and environmental influences helps you feel prepared. In this condition, the main known risk comes from a change that is already present from conception, while clear outside causes have not been proven.
Many cases of Diamond-Blackfan anemia 13 begin with a chance change that arises in the egg, sperm, or very early embryo. This can happen even when no one else in the family is affected and no outside trigger is found.
No medicine, infection, pollutant, or routine pregnancy exposure has been clearly proven to cause Diamond-Blackfan anemia 13. For many families, this means nothing obvious during pregnancy or daily life can be identified as the reason.
Common maternal illnesses during pregnancy have not been established as specific risk factors for Diamond-Blackfan anemia 13. They may affect pregnancy in other ways, but they are not known to directly lead to this condition.
Genetic risk factors
Diamond-Blackfan anemia 13 is linked to a change in RPS29, a gene that helps the body make ribosomes, the tiny structures cells use to build proteins. When that system is disrupted, the bone marrow may not make enough red blood cells. Carrying a genetic change doesn’t guarantee the condition will appear. In some families the change is inherited, while in others it happens for the first time in the child.
RPS29 changes: Among the genetic causes of Diamond-Blackfan anemia 13, changes in the RPS29 gene are the main known cause. This gene helps build ribosomes, and when one copy does not work properly, red blood cell production can be affected.
New mutation: Many cases happen because the gene change starts new in the child rather than being inherited from a parent. This is why some families have no previous history of Diamond-Blackfan anemia 13.
Family history: When a parent carries the same RPS29 change, each pregnancy has a 50% chance of passing it on. Sometimes the parent has very mild signs or no clear problems, so the pattern may only become obvious after testing.
Dominant inheritance: Diamond-Blackfan anemia 13 usually follows an autosomal dominant inheritance pattern. That means one altered copy of the gene can be enough to cause the condition.
Variable effect: The same genetic change can affect family members very differently. Some become severely anemic in infancy, while others have milder findings or are diagnosed only after a relative is tested.
Lifestyle risk factors
Lifestyle habits do not cause Diamond-Blackfan anemia 13, but they can influence fatigue, infection risk, bone health, and treatment-related complications. In practice, how lifestyle affects Diamond-Blackfan anemia 13 often depends on whether a person is dealing with chronic anemia, steroid therapy, or transfusion-related issues. The most helpful habits are those that support energy balance, reduce added strain on the body, and work alongside medical treatment.
Poor overall nutrition can worsen weakness and make it harder to cope with chronic anemia in Diamond-Blackfan anemia 13. Regular meals with enough protein, calories, folate, vitamin B12, and other nutrients can support red blood cell production and recovery, even though they do not correct the underlying disorder.
Extra iron from supplements should not be taken unless a clinician recommends it, because some people with Diamond-Blackfan anemia 13 develop iron overload from transfusions. Avoiding unnecessary iron can help limit added stress on the liver, heart, and endocrine organs.
Too little activity can reduce stamina and muscle strength, while overly intense exercise may worsen shortness of breath, dizziness, or exhaustion when anemia is significant. Gentle, individualized activity can help maintain conditioning and daily function without pushing beyond safe limits.
Poor sleep can intensify fatigue, concentration problems, and low mood that may already accompany chronic anemia. Consistent sleep timing and enough rest can improve day-to-day energy and coping.
Risk prevention
Diamond-Blackfan anemia 13 is usually present from birth, so there is no known way to prevent the condition itself if you carry the gene change. For many living with Diamond-Blackfan anemia 13, prevention is mostly about lowering the chance of complications such as severe anemia, infections, iron overload, and growth or organ problems. Prevention is flexible—it adapts to your life and health background. Early, regular care also helps doctors spot problems before they become more serious.
If Diamond-Blackfan anemia 13 runs in your family, genetic counseling can help you understand the chance of passing it on. It can also help with family planning decisions and testing options before or during pregnancy.
Routine blood tests help catch worsening anemia early, sometimes before the early symptoms of Diamond-Blackfan anemia 13 become obvious day to day. This makes it easier to adjust treatment and lower the risk of fainting, strain on the heart, or poor growth.
People with Diamond-Blackfan anemia 13 may need extra care to avoid infections, especially if treatment affects the immune system. Handwashing, recommended vaccines, and quick medical advice for fever can help prevent serious illness.
Repeated blood transfusions can cause iron to build up in the body over time. Regular monitoring and iron-lowering treatment, when needed, can help protect the heart, liver, and hormone glands.
Can you prevent Diamond-blackfan anemia 13?
Diamond-Blackfan anemia 13 cannot usually be prevented. It is a rare condition people are born with, caused by a change in a gene that happens before birth and may be passed down in some families or happen for the first time in a child. If it runs in your family, genetic counseling before pregnancy may help you understand the chances for a baby, but it cannot fully prevent the condition.
Transmission
Diamond-Blackfan anemia 13 is not infectious, so it cannot spread from one person to another through everyday contact, coughing, kissing, sex, blood, or food. Instead, the genetic transmission of Diamond-Blackfan anemia 13 involves a change in a gene that affects how the body makes red blood cells.
Many people with Diamond-Blackfan anemia 13 inherit that gene change from a parent, and if a parent carries it, each child may have a 1 in 2, or 50%, chance of inheriting it. In some families, though, the gene change is new in the child and was not present in either parent, so Diamond-Blackfan anemia 13 can appear even when there is no known family history.
When to test your genes
Consider genetic testing if a baby or child has unexplained severe anemia, especially in the first year of life, or has birth differences such as thumb, heart, or growth changes. Testing also helps if there is a family history of Diamond-Blackfan anemia, because results can guide monitoring, treatment, and family planning.
Diagnosis
Diamond-Blackfan anemia 13 is usually diagnosed when a baby or child has signs of anemia, such as unusual tiredness, pale skin, poor feeding, or slow growth, and doctors then look for a pattern that fits this rare inherited bone marrow condition. The diagnosis often starts with blood findings and a careful physical exam, then is confirmed with more specific tests, including genetic testing. Getting a diagnosis is often a turning point toward answers and support.
Doctors usually begin with a complete blood count to check for low red blood cells and to see whether the red cells are larger than expected. Reticulocyte levels are often low, which suggests the bone marrow is not making enough new red blood cells.
A bone marrow test may be done if the blood results suggest Diamond-Blackfan anemia 13 or if the cause of anemia is still unclear. It typically shows a marked decrease in red blood cell precursors while other blood-forming cells are relatively preserved.
Doctors look for physical findings that can occur in Diamond-Blackfan anemia 13, such as small stature, thumb or arm differences, head and face differences, or heart and kidney problems. Not everyone has these features, so their absence does not rule the condition out.
The genetic diagnosis of Diamond-Blackfan anemia 13 is made by finding a disease-causing change in the RPL5 gene. Genetic testing helps confirm the diagnosis, guide family counseling, and sometimes clarify whether other relatives may be affected.
How is Diamond-blackfan anemia 13 diagnosed?
Diamond-Blackfan anemia 13 is usually diagnosed using a child’s medical history, a physical exam, and blood tests that show anemia, meaning too few red blood cells, often with the body making unusually few new red blood cells. Doctors may also check the soft center of the bones where blood cells are made to see whether red blood cell production is very low, and genetic testing can help confirm the diagnosis by finding the gene change linked to the type 13 form.
Stages of Diamond-blackfan anemia 13
Diamond-Blackfan anemia 13 does not have defined progression stages. This is because it is usually a lifelong inherited condition identified by low red blood cell production and related features, rather than an illness that moves through clear step-by-step phases over time. Often the process begins when you notice changes in daily life, such as unusual tiredness, pale skin, poor feeding, or slow growth, which can be early symptoms of Diamond-Blackfan anemia 13. Doctors usually diagnose and monitor it with blood tests, physical exams, and sometimes genetic testing, while follow-up visits help track anemia, growth, and any treatment effects.
Outlook and prognosis
The outlook for people with Diamond-Blackfan anemia 13 is variable and depends largely on how severe the anemia is, whether birth defects or growth problems are present, and how well the person responds to treatment. Many affected individuals can achieve good long-term control with corticosteroids, chronic transfusion support, or hematopoietic stem cell transplantation, but each option carries important risks such as iron overload, treatment toxicity, or transplant-related complications. Some people have periods of improved blood counts, while others need lifelong monitoring and ongoing therapy. Life expectancy has improved markedly with modern supportive care, especially when iron overload and other complications are recognized early and treated appropriately. Mortality can occur from severe anemia, infection, heart or liver disease related to transfusional iron overload, or complications of transplantation, although precise subtype-specific mortality data for Diamond-Blackfan anemia 13 are limited. Long-term follow-up is also important because Diamond-Blackfan anemia is associated with an increased risk of certain cancers in adulthood.
Long-term effects
For many living with Diamond-Blackfan anemia 13, the biggest long-term effects relate to low red blood cell production and how that shapes growth, energy, and other organs over time. Long-term effects vary widely, and some people have mild day-to-day limits while others need ongoing treatment for years. In childhood, this may show up as tiring easily at school or needing more medical care than other kids, while in adulthood the focus often shifts to organ health, hormones, and cancer screening. The long-term effects of Diamond-Blackfan anemia 13 also depend on whether someone has birth differences, ongoing anemia, or treatment-related complications.
Ongoing low red blood cell levels can cause lasting fatigue, weakness, shortness of breath, and reduced exercise tolerance. For many, this can mean getting worn out by stairs, sports, or a full day of work or school.
Some children with Diamond-Blackfan anemia 13 grow more slowly than expected and may be shorter than average as they get older. Delayed puberty can also happen, especially when anemia is persistent or treatment has been intensive.
Many people with Diamond-Blackfan anemia 13 have long-term physical differences present from birth, such as changes in the thumbs, arms, face, heart, or kidneys. These features do not affect everyone, but when present they can have lifelong effects on health and development.
People who need repeated blood transfusions can build up too much iron in the body over time. Excess iron may damage the heart, liver, and hormone-producing glands, sometimes years after the early symptoms of Diamond-Blackfan anemia 13 were first noticed.
How is it to live with Diamond-blackfan anemia 13?
Living with Diamond-Blackfan anemia 13 often means living with chronic anemia, so many people feel unusually tired, short of breath, pale, or less able to keep up with school, work, exercise, and everyday routines, especially when blood counts are low. Daily life may also revolve around treatment, such as regular checkups, blood tests, steroid medicines for some, or blood transfusions for others, and some people are also managing birth differences or growth concerns that can add practical and emotional strain. For families and close friends, this can mean helping with medical appointments, watching for symptoms, and adjusting plans around fatigue or treatment needs, but with steady care and support, many people with Diamond-Blackfan anemia build full and meaningful daily lives.
Treatment and drugs
Treatment for Diamond-Blackfan anemia 13 focuses on helping the body make enough red blood cells and preventing problems from long-term anemia. Many living with Diamond-Blackfan anemia 13 are treated first with corticosteroids, which can raise red blood cell counts, while others may need regular blood transfusions, especially if steroids do not work well or cause side effects. It’s common to try more than one medication before doctors settle on the approach that keeps anemia under the best control with the fewest downsides. If transfusions are needed over time, treatment may also include medicines to lower extra iron that can build up in the body, and in some cases a stem cell transplant may be considered because it can offer the best chance of a long-term cure. Alongside medical treatment, lifestyle choices play a role, and regular follow-up helps track growth, energy levels, heart health, and any treatment side effects.
Can you cure Diamond-blackfan anemia 13?
There is no simple cure for Diamond-Blackfan anemia 13 itself, because it is caused by a change in a gene. For some people, a bone marrow or stem cell transplant can cure the blood-related part of the condition, but it is a major treatment and is not right for everyone. For many living with this condition, treatment focuses on raising red blood cell levels and easing symptoms with medicines such as steroids or with blood transfusions.
Non-drug treatment
Day-to-day care for Diamond-Blackfan anemia 13 often centers on keeping oxygen levels up, watching for complications, and supporting growth and development. While medicines are important for some people, non-drug treatment for Diamond-Blackfan anemia 13 can also play a major role, especially when symptoms affect energy, school, work, or regular routines. Care is usually tailored, because some people mainly need monitoring while others need transfusions, specialist care, or a stem cell transplant.
Regular red blood cell transfusions can raise hemoglobin and improve fatigue, shortness of breath, and poor stamina. For many, treatment begins not at the pharmacy, but in an infusion center where planned transfusions help support daily life.
A hematopoietic stem cell transplant, also called a bone marrow transplant, may be used in some people to replace the blood-forming cells that are not working well. This is the main treatment with curative potential, but it is only suitable in selected situations after careful specialist review.
Ongoing follow-up with a blood specialist helps track anemia, growth, heart strain, and transfusion needs over time. Routine blood tests and checkups can also help catch problems early, including changing symptoms or signs of iron buildup from repeated transfusions.
Children living with Diamond-Blackfan anemia 13 may need close tracking of height, weight, feeding, and development. Supportive therapies can include nutrition advice, feeding support, and early developmental services when low energy or other health issues make progress harder.
Your genes may have an impact on how drugs work for you
For people with Diamond-Blackfan anemia 13, the same medicine does not always work the same way for everyone, especially with steroid treatment that is often used to help the body make more red blood cells. Some may have a good rise in blood counts, while others get little benefit or have more side effects, in part because the genetic change behind the condition can affect how well the blood-making cells in the bone marrow respond. Genes can also influence how the body handles medicines, but using genetic testing to choose treatment is not yet a routine part of care for Diamond-Blackfan anemia 13.
Pharmacological treatments
For many living with Diamond-Blackfan anemia 13, medicine treatment mainly means trying steroids to help the bone marrow make more red blood cells. If regular blood transfusions are needed, drugs may also be used to prevent iron from building up in the body over time. There is no widely used medicine that fixes the underlying gene change, so treatment is tailored to symptoms, blood counts, and how someone responds. Not everyone responds to the same medication in the same way.
These corticosteroids are the main medicines used to raise red blood cell production in Diamond-Blackfan anemia 13. They can improve anemia in some people, sometimes reducing the need for transfusions. Because side effects can be significant, doctors aim for the lowest effective dose and monitor growth, blood pressure, blood sugar, and bone health.
These iron-chelating drugs are used when ongoing transfusions cause iron overload, which can damage the heart, liver, and hormone glands. They do not treat the root cause of Diamond-Blackfan anemia 13, but they are an important part of long-term care for people who are transfusion-dependent. In practice, they often become part of treatment for Diamond-Blackfan anemia 13 after repeated transfusions.
Genetic influences
For families living with Diamond-Blackfan anemia 13, the genetic cause is usually clear: this subtype is linked to a change in the RPS29 gene. This gene helps cells make ribosomes, the structures that build proteins, and when it is altered, the bone marrow may not make enough red blood cells, which leads to anemia and can sometimes affect growth or cause other physical differences. It’s natural to ask whether family history plays a role. In Diamond-Blackfan anemia 13, one altered copy of RPS29 is typically enough to cause the condition, so it can be passed down from a parent, although the gene change may also happen for the first time in a child. Symptoms can vary even within the same family, which means one relative may have more severe anemia while another has milder signs, and genetic testing can help confirm the diagnosis and clarify the chance of it happening again in the family.
Is Diamond-blackfan anemia 13 genetic?
Genetics are central to Diamond-Blackfan anemia 13, which is usually caused by a harmful change in a single gene. These genetic variations often explain why it runs in families, though severity can vary even among relatives.
Having a genetic risk is not necessarily a diagnosis
Gene variants are a normal part of human biology and are common across the general population. Most do not directly affect health and simply reflect natural human diversity. For many genes, having a variant linked to a condition suggests a possible connection rather than a definite diagnosis, especially when more than one gene and environmental factors are involved. In some cases, though, a single well-understood variant in a specific gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
In Diamond-Blackfan anemia 13, the specific gene change matters because it helps doctors confirm that low red blood cell production is part of an inherited bone marrow condition, not a different kind of anemia. This can shape treatment decisions, including whether to try steroid medicines, when regular blood transfusions may be needed, and whether a stem cell transplant should be considered. Not every difference in response is genetic, but in Diamond-Blackfan anemia 13 there is not yet a routine pharmacogenetic test that can reliably tell which medicine will work best or who will have side effects from standard treatment. Even so, genetic testing for Diamond-Blackfan anemia 13 treatment can still be very useful, because it guides family testing, helps doctors avoid using a related stem cell donor who may carry the same condition, and supports monitoring for health issues that can occur alongside the anemia. For many living with Diamond-Blackfan anemia 13, this means genetics is used more to guide the overall care plan than to fine-tune drug doses in the way it does for some other conditions.
Interactions with other conditions
For many living with Diamond-Blackfan anemia 13, health concerns may extend beyond low red blood cell counts, especially if regular transfusions or steroid treatment are needed over time. Doctors call it a comorbidity when two conditions occur together, and with Diamond-Blackfan anemia 13 this can include iron overload from transfusions, which may affect the heart, liver, and hormone-producing glands if it is not closely monitored. Some people also have birth differences, such as problems involving the heart, kidneys, thumbs, or face, so care may involve several specialists rather than hematology alone. Steroid treatment can help raise blood counts, but it may also increase the risk of bone thinning, slower growth, higher blood sugar, or infections, which can make day-to-day care more complicated. There is also a small but important increased risk of certain cancers, including blood cancers and some solid tumors, so long-term follow-up matters even when the early symptoms of Diamond-Blackfan anemia 13 seem stable. Because this condition can overlap with other medical issues in different ways, regular checkups and coordinated care help catch problems early and support overall health.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Diamond-blackfan anemia 13?
Other problems that can look similar include a temporary drop in red blood cell production after a viral illness, low iron, or blood loss, all of which can cause a baby or child to look pale, tired, or weak. Doctors may also check for other inherited conditions that affect the bone marrow, especially Fanconi anemia, because these can also cause anemia and sometimes birth differences or slow growth. Since Diamond-Blackfan anemia 13 mainly lowers red blood cell production, testing is usually needed to tell it apart from these other causes.
History
Families and communities once noticed patterns in children who seemed unusually pale, tired, or slower to grow, even when other causes were not clear. What doctors now group under Diamond-Blackfan anemia 13 became easier to recognize only after physicians began carefully comparing these shared features across different families and over time. In day-to-day life, this could mean an infant who struggled with feeding and low energy, or a child who needed repeated medical visits because routine blood tests showed severe anemia.
The broader condition, Diamond-Blackfan anemia, was first described in the 1930s, when doctors Louis Diamond and Kenneth Blackfan reported infants with a particular form of anemia that started early in life. At first, understanding came mainly from what could be seen: low red blood cell production, weakness, poor growth in some children, and, in some cases, differences present from birth. As medical science evolved, doctors learned that Diamond-Blackfan anemia was not just one single, identical illness in every child, but a group of closely related forms that can vary from person to person.
That later helped explain why some people with Diamond-Blackfan anemia 13 may have somewhat different features or a different course than others living with Diamond-Blackfan anemia. In recent decades, better laboratory testing and genetic research made it possible to separate these forms more precisely, including Diamond-Blackfan anemia 13, which is one of the recognized subtypes. This shift mattered for families: it gave a clearer explanation for early symptoms of Diamond-Blackfan anemia, helped guide follow-up care, and improved counseling about what to expect.
The history of Diamond-Blackfan anemia 13 is therefore part of a larger medical story. What began as careful bedside observation in babies and children with severe anemia gradually became a more detailed understanding of a rare inherited bone marrow condition. While the names and classifications have become more precise, the main goal has stayed the same: to recognize the condition early, support healthy growth and development, and help people with Diamond-Blackfan anemia receive care that fits their needs.